Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation

BACKGROUND: Pretransplant therapies such as rituximab and plasmapheresis have led to an increase in ABO-incompatible (ABOi) living donor liver transplantation (LDLT), thus helping to overcome organ shortages. This study evaluated the changes in anti-A/B titers and CD19 levels over time in patients u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Suk Kyun, Lee, Kwang-Woong, Kim, Jae-Yoon, Lee, Jaewon, Kim, Jiyoung, Choi, Hyun Hwa, Hong, Su young, Lee, Jeong-Moo, Choi, YoungRok, Yi, Nam-Joon, Suh, Kyung-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Transplantation 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583967/
https://www.ncbi.nlm.nih.gov/pubmed/37694598
http://dx.doi.org/10.4285/kjt.23.0031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583967/
https://www.ncbi.nlm.nih.gov/pubmed/37694598
http://dx.doi.org/10.4285/kjt.23.0031

Ejemplares similares